Category: Regulation & Policy
Global Regulation & Policy
-
Analytical Standards Global Market Opportunities And Strategies To 2030: COVID-19 Growth And Change
... and senior management with the critical information they need to assess the global analytical standards market as it emerges from the COVID 19 shut down. Reasons to Purchase Gain a truly global perspective with the ... Read More
-
Pharmacovigilance And Drug Safety Software Market Size, Share & Trends Analysis Report By Functionality, By Delivery Mode (On Premise, On Demand), By End-use, By Region, And Segment Forecasts, 2022 - 2030
... Research, Inc. The market is expected to expand at a lucrative CAGR of 10.5% from 2022 to 2030. The key factors driving the market growth include increasing need to track and manage adverse drug reactions ... Read More
-
Global Pharmacovigilance Market - 2022-2029
... with the detection, understanding, assessment, and prevention of adverse effects or any other drug-related problem. The focus of pharmacovigilance is on ADR (adverse drug reactions) and drug toxicity. The pharmacovigilance market comprises all types of ... Read More
-
The 2023-2028 World Outlook for Clinical Research Organizations (CROs)
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2023-2028 World Outlook for GxP-GMP Regulation Testing Services
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2023-2028 World Outlook for Post-Marketing Pharmacovigilance and Medical Information
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2023-2028 World Outlook for Orphan Drugs
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2023-2028 World Outlook for Pharmacovigilance
... for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis ... Read More
-
The 2023-2028 World Outlook for Pharmacovigilance Technologies
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2023-2028 World Outlook for Pharmacovigilance and Drug Safety Software
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2023-2028 World Outlook for Counterfeit Drug Detection Devices
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
IDC Perspective: Real-World Evidence and Drug Pricing in 2022
... patients, private and government healthcare payers, life science companies, and society at large. "As life science companies, private and public healthcare payers, and healthcare providers learn to use RWE to discover the true value of ... Read More
-
Testing, Inspection, and Certification Market with Covid-19 Impact Analysis by Service Type (Testing, Inspection, and Certification), Sourcing Type (In-house, Outsourced), Application and Geography - Global Forecast to 2027
... projected to reach USD 268.9 billion by 2027 from USD 221.4 billion in 2022; it is expected to grow at a CAGR of 4.0% from 2022 to 2027. The growth of the Testing, inspection, and ... Read More
-
Orphan Drugs Market by Disease Type (Oncological Diseases, Metabolic Diseases, Hematologic & Immunologic Diseases, Infectious Diseases, Neurologic Diseases, and Other Rare Diseases): Global Opportunity Analysis and Industry Forecast, 2021–2030
... valued at $1,40,000.0 million in 2020 and is projected to reach $4,35,686.3 million by 2030 registering a CAGR of 11.8% from 2021 to 2030. The pharmaceutical agents administered to treat, diagnose, and prevent life-threatening diseases ... Read More
-
Global Orphan Drugs Market Research Report 2022
... in 2021, at a CAGR of 9.86% during 2022-2028. Fully considering the economic change by this health crisis, Oncology accounting for 63.30% of the Orphan Drugs global market in 2021, is projected to value US$ ... Read More
-
Global and United States Computational Toxicology Solutions Market Size, Status and Forecast 2022-2028
... Toxicology Solutions market, also covers the segmentation data of other regions in regional level and county level. Based on our recent survey, we have several different scenarios about the Computational Toxicology Solutions YoY growth rate ... Read More
-
Counterfeit Drug Detection Devices Market - Global Industry Analysis (2018 - 2020) - Growth Trends and Market Forecast (2021 - 2026)
... devices market continues to benefit significantly from the rising awareness about sizeably large markets operating on adulterated pharmaceuticals packaging, and counterfeit medicines. A new Fairfield Market Research report suggests that an increasing number of anti-counterfeiting ... Read More
-
Pharmacovigilance and Drug Safety Software Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... is expected to reach approximately USD 238.68 million in 2026, registering a CAGR of nearly 6.49% during the forecast period. The evolving threat of COVID-19 infection is adversely affecting communities, industries, businesses, and lives around ... Read More
-
Pharmacovigilance Market Size, Share & Trends Analysis Report By Product Life Cycle, By Service Provider, By Type, By Process Flow, By Therapeutic Area, By End-use, By Region, And Segment Forecasts, 2022 - 2030
... a CAGR of 10.5% from 2022 to 2030. Increasing incidence of Adverse Drug Reactions (ADRs) is the key growth driver. ADR imposes a substantial burden on healthcare systems and is one of the prominent causes ... Read More
-
Pharmaceutical Sterility Testing Market - By Type (In-House And Outsourcing), By Test Type (Sterility Testing, Bioburden Testing, And Bacterial Endotoxin Testing), By Sample (Sterile Drugs, Medical Devices, And Biologics & Therapeutics), By End-Use (Compounding Pharmacies, Medical Devices Companies, And Pharmaceutical Companies), And By Region- Global Industry Perspective, Comprehensive Analysis, And Forecast, 2021 – 2030
... Medical Devices Companies, And Pharmaceutical Companies), And By Region- Global Industry Perspective, Comprehensive Analysis, And Forecast, 2021 – 2030 Market Overview Fatpos Global has released a report titled Pharmaceutical Sterility Testing Market - Analysis of ... Read More
-
NASH Drug Pipeline and Market Overview
... of the liver (cirrhosis). No medications have been approved specifically for NASH but there are numerous products in development. NASH Drug Pipeline and Market Overview looks at the almost 80 drug candidates for the treatment ... Read More
Research Assistance
